Teng-Kuang Yeh, Ph.D.
Affiliations: | 2002 | Ohio State University, Columbus, Columbus, OH |
Area:
Pharmacy, Pharmacology, OncologyGoogle:
"Teng-Kuang Yeh"Parents
Sign in to add mentor| Jessie L. Au | grad student | 2002 | Ohio State | |
| (Pharmacokinetics of anti -AIDS and anti -cancer drugs: Implications on drug delivery and drug interaction.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen YY, Lo CF, Chiu TY, et al. (2020) BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy. Translational Oncology. 14: 100897 |
| Chen YJ, Tsai CY, Cheng YM, et al. (2020) Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System. Scientific Reports. 10: 2838 |
| Lu Z, Yeh TK, Wang J, et al. (2011) Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy. The Journal of Urology. 185: 1478-83 |
| Au JL, Lu Z, Yeh T, et al. (2009) RAPID RELEASE PACLITAXEL NANOPARTICLES FOR INTRAVESICAL THERAPY IN DOGS WITH SPONTANEOUS BLADDER CANCER The Journal of Urology. 181: 635 |
| Villalona-Calero MA, Otterson GA, Wientjes MG, et al. (2008) Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 19: 1903-9 |
| Tsai M, Lu Z, Wang J, et al. (2007) Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel. Pharmaceutical Research. 24: 1691-701 |
| Au JLS, Olencki T, Wientjes MG, et al. (2007) P2-230: A Phase I Study of Nontoxic Suramin As A Chemosensitizer In Pretreated/Refractory Non-Small Cell Lung Cancer (NSCLC) Patients Journal of Thoracic Oncology. 2 |
| Chen D, Song SH, Wientjes MG, et al. (2006) Nontoxic suramin as a chemosensitizer in patients: dosing nomogram development. Pharmaceutical Research. 23: 1265-74 |
| Olencki T, Wientjes G, Otterson G, et al. (2005) Modulation of chemotherapy resistance with low dose suramin in refractory non-small cell lung cancer (NSCLC) patients: A phase I study of sequential non-cross resistant chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2104 |
| Yeh TK, Lu Z, Wientjes MG, et al. (2005) Formulating paclitaxel in nanoparticles alters its disposition. Pharmaceutical Research. 22: 867-74 |